Johnson & Johnson (JNJ) live share price

Johnson & Johnson share price in USD $154.8 & INR ₹13,110.79

$154.8

▲

-0.21

(-0.14%)

View live Johnson & Johnson share price in Dollar and Rupees. Guide to invest in Johnson & Johnson from India. Also see the sentimental analysis on Indian investors investing in Johnson & Johnson. Get details on the Indian mutual funds that are investing in Johnson & Johnson. Get Analyst recommendations and forecasts along with all the Johnson & Johnson's financials.

Johnson & Johnson share price movements

$153.94
$154.98
$154.80
0.56%
Downside
Day's Volatility :0.67%
Upside
0.12%
$143.13
$168.85
$154.80
7.54%
Downside
52 Weeks Volatility :15.23%
Upside
8.32%

Johnson & Johnson Returns

Period	Johnson & Johnson	Sector (Health Care)	Index (NASDAQ Composite)
3 Months	-7.27%	-6.2%	8.1%
6 Months	4.88%	2.6%	16.1%
1 Year	-2.44%	11.8%	23.9%
3 Years	-4.87%	13.3%	29.7%

Johnson & Johnson Key Statistics

in dollars & INR

Market Capitalization	$373.6B
Revenue TTM	$87.7B
EBITDA	$30.1B
Earnings Per Share (EPS)	$6.05
PE Ratio	25.65
Dividend Yield	3.2%
Profit Margin	16.74%
Quarterly Earnings Growth YOY	-0.89%
Return On Equity TTM	20.89%

How to invest in Johnson & Johnson from India?

It is very easy for Indian residents to invest directly in Johnson & Johnson from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Johnson & Johnson stock in both rupees (INR) and dollars (USD). Search for Johnson & Johnson or JNJ on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Johnson & Johnson or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Johnson & Johnson shares which would translate to 0.005 fractional shares of Johnson & Johnson as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Johnson & Johnson

23.78%

Period: Sep 3, 2024 to Dec 2, 2024. Change in 30 Days versus previous period

Investment in Johnson & Johnson from India has grown in the last 30 days as on Dec 3, 2024. 23.78% more purchase transactions for Johnson & Johnson in the last 30 days versus the previous period.

68%

Period: Sep 3, 2024 to Dec 2, 2024. Change in 30 Days versus previous period

Search volume for Johnson & Johnson on INDmoney from India has grown in the last 30 days as on Dec 3, 2024. 68% more investors are searching Johnson & Johnson in the last 30 days versus the previous period.

Indian Mutual Funds that own Johnson & Johnson

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	20686	-114.19	0.79%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	3373	1033.15	2.89%

Global Institutional Holdings in Johnson & Johnson

Vanguard Group Inc
9.60%
BlackRock Inc
8.23%
State Street Corp
5.53%
Morgan Stanley - Brokerage Accounts
3.49%
Geode Capital Management, LLC
2.33%
State Farm Mutual Automobile Ins Co
1.32%

Analyst Recommendation on Johnson & Johnson

Buy

53%Buy

46%Hold

0%Sell

Based on 28 Wall street analysts offering stock ratings for Johnson & Johnson(by analysts ranked 0 to 5 stars)

Based on 28 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Johnson & Johnson

What analysts predicted

Upside of 12.98%

Current:

$154.80

Target:

$174.89

Insights on Johnson & Johnson

Increasing Revenue
Revenue is up for the last 3 quarters, 21.38B → 22.47B (in $), with an average increase of 2.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 4.68B → 2.69B (in $), with an average decrease of 42.5% per quarter
Vs PG
In the last 1 year, Procter & Gamble Company, The has given 17.4% return, outperforming this stock by 19.5%
Vs PG
In the last 3 years, Procter & Gamble Company, The has given 21.7% return, outperforming this stock by 23.0%

Johnson & Johnson Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$81.6B	↑ 6.71%
Net Income	$15.3B	↑ 1076.69%
Net Profit Margin	18.75%	↑ 17.05%

	FY19	Y/Y Change
Revenue	$82.1B	↑ 0.59%
Net Income	$15.1B	↓ 1.16%
Net Profit Margin	18.42%	↓ 0.33%

	FY20	Y/Y Change
Revenue	$82.6B	↑ 0.64%
Net Income	$14.7B	↓ 2.68%
Net Profit Margin	17.82%	↓ 0.6%

	FY21	Y/Y Change
Revenue	$78.7B	↓ 4.65%
Net Income	$20.9B	↑ 41.89%
Net Profit Margin	26.52%	↑ 8.7%

	FY22	Y/Y Change
Revenue	$80.0B	↑ 1.59%
Net Income	$17.9B	↓ 14.07%
Net Profit Margin	22.43%	↓ 4.09%

	FY23	Y/Y Change
Revenue	$85.2B	↑ 6.46%
Net Income	$35.2B	↑ 95.94%
Net Profit Margin	41.28%	↑ 18.85%

	Q2 FY23	Q/Q Change
Revenue	$25.5B	↑ 3.28%
Net Income	$5.1B	↓ 7664.71%
Net Profit Margin	20.14%	↑ 20.41%

	Q3 FY23	Q/Q Change
Revenue	$21.4B	↓ 16.42%
Net Income	$26.0B	↑ 405.99%
Net Profit Margin	121.91%	↑ 101.77%

	Q4 FY23	Q/Q Change
Revenue	$21.4B	↑ 0.21%
Net Income	$4.0B	↓ 84.44%
Net Profit Margin	18.92%	↓ 102.99%

	Q1 FY24	Q/Q Change
Revenue	$21.4B	↓ 0.06%
Net Income	$3.3B	↓ 19.61%
Net Profit Margin	15.22%	↓ 3.7%

	Q2 FY24	Q/Q Change
Revenue	$22.4B	↑ 4.98%
Net Income	$4.7B	↑ 43.96%
Net Profit Margin	20.88%	↑ 5.66%

	Q3 FY24	Q/Q Change
Revenue	$22.5B	↑ 0.11%
Net Income	$2.7B	↓ 42.51%
Net Profit Margin	11.99%	↓ 8.89%

	FY18	Y/Y Change
Total Assets	$153.0B	↓ 2.76%
Total Liabilities	$93.2B	↓ 4.06%

	FY19	Y/Y Change
Total Assets	$157.7B	↑ 3.12%
Total Liabilities	$98.3B	↑ 5.42%

	FY20	Y/Y Change
Total Assets	$174.9B	↑ 10.88%
Total Liabilities	$111.6B	↑ 13.6%

	FY21	Y/Y Change
Total Assets	$182.0B	↑ 4.07%
Total Liabilities	$108.0B	↓ 3.24%

	FY22	Y/Y Change
Total Assets	$187.4B	↑ 2.94%
Total Liabilities	$110.6B	↑ 2.39%

	FY23	Y/Y Change
Total Assets	$167.6B	↓ 10.58%
Total Liabilities	$98.8B	↓ 10.66%

	Q2 FY23	Q/Q Change
Total Assets	$191.7B	↓ 2.19%
Total Liabilities	$115.3B	↓ 7.85%

	Q3 FY23	Q/Q Change
Total Assets	$166.1B	↓ 13.37%
Total Liabilities	$94.8B	↓ 17.73%

	Q4 FY23	Q/Q Change
Total Assets	$167.6B	↑ 0.9%
Total Liabilities	$98.8B	↑ 4.17%

	Q1 FY24	Q/Q Change
Total Assets	$172.0B	↑ 2.63%
Total Liabilities	$101.9B	↑ 3.2%

	Q2 FY24	Q/Q Change
Total Assets	$181.1B	↑ 5.3%
Total Liabilities	$109.6B	↑ 7.46%

	Q3 FY24	Q/Q Change
Total Assets	$178.3B	↓ 1.55%
Total Liabilities	$108.1B	↓ 1.3%

	FY18	Y/Y Change
Operating Cash Flow	$22.2B	↑ 5.44%
Investing Cash Flow	$-3.2B	↓ 78.7%
Financing Cash Flow	$-18.5B	↑ 141.24%

	FY19	Y/Y Change
Operating Cash Flow	$23.4B	↑ 5.47%
Investing Cash Flow	$-6.2B	↑ 95.58%
Financing Cash Flow	$-18.0B	↓ 2.67%

	FY20	Y/Y Change
Operating Cash Flow	$23.5B	↑ 0.51%
Investing Cash Flow	$-20.8B	↑ 236.21%
Financing Cash Flow	$-6.1B	↓ 66.03%

	FY21	Y/Y Change
Operating Cash Flow	$23.4B	↓ 0.54%
Investing Cash Flow	$-8.7B	↓ 58.3%
Financing Cash Flow	$-14.0B	↑ 129.53%

	FY22	Y/Y Change
Operating Cash Flow	$21.2B	↓ 9.47%
Investing Cash Flow	$-12.4B	↑ 42.47%
Financing Cash Flow	$-8.9B	↓ 36.85%

	FY23	Y/Y Change
Operating Cash Flow	$22.8B	↑ 7.54%
Investing Cash Flow	$878.0M	↓ 107.1%
Financing Cash Flow	$-15.8B	↑ 78.39%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$4.2B	↑ 28.4%
Investing Cash Flow	$-3.8B	↓ 213.91%
Financing Cash Flow	$-6.0B	↓ 197.61%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$7.5B	↑ 79.08%
Investing Cash Flow	$2.5B	↓ 167.29%
Financing Cash Flow	$-11.3B	↑ 88.9%

	Q4 FY23	Q/Q Change
Operating Cash Flow	$7.9B	↑ 4.99%
Investing Cash Flow	$-1.2B	↓ 147.3%
Financing Cash Flow	$-4.7B	↓ 58.87%

	Q1 FY24	Q/Q Change
Operating Cash Flow	$3.7B	↓ 53.49%
Investing Cash Flow	$-464.0M	↓ 61.4%
Financing Cash Flow	$546.0M	↓ 111.73%

Johnson & Johnson Technicals Summary

Sell

Neutral

Buy

Johnson & Johnson is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Johnson & Johnson Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Johnson & Johnson	-2.04%	4.88%	-2.44%	-4.87%	11.07%
Procter & Gamble Company, The	8.59%	7.33%	17.89%	17.82%	43.85%
Pfizer Inc.	-5.58%	-11.12%	-10.48%	-49.09%	-31.08%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Johnson & Johnson	25.65	25.65	0.92	9.96	0.21	0.08	0.03	29.14
Procter & Gamble Company, The	30.96	30.96	3.79	6.55	0.29	0.11	0.02	21.68
Pfizer Inc.	34.95	34.44	0.18	2.93	0.05	0.03	0.07	16.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Johnson & Johnson	Buy	$373.6B	11.07%	25.65	16.74%
Procter & Gamble Company, The	Buy	$422.2B	43.85%	30.96	17.06%
Pfizer Inc.	Hold	$148.5B	-31.08%	34.95	7.16%

Johnson & Johnson Dividend announcements

Johnson & Johnson Dividends June, 2024
In the quarter ending June,2024. Johnson & Johnson has declared dividend of $1.24
Read More

About Johnson & Johnson

Johnson & Johnson - a multinational corporation founded in America - mainly caters to medical and consumer goods. The company's headquarters are in New Jersey, United States. The company was incorporated in 1886 by James, Robert, and Edward Mead Johnson. Johnson & Johnson is one of the world's most valuable corporations. It has nearly 250 subsidiary companies operating across 60 countries. Its products are selling in over 175 countries. Some well-known consumer products of Johnson & Johnson are Band-Aids, baby products, Tylenol medications, and other products. In 2020, Johnson & Johnson generated annual revenue of $82.584 billion. Joaquin Duato serves as the Chairman and CEO for Johnson & Johnson, along with Paul Stoffels as Vice Chairman of the Executive Committee for the company with several other members. The company was ranked 36 on the Fortune 500 list of the top corporations in the United States by total revenue in 2021. Johnson & Johnson is publicly traded on New York Stock Exchange as JNJ as its stock symbol, under the DJIA, S&P 100, and S&P 500. Currently Johnson & Johnson has a market cap of $395.34 Billion. It has a P.E ratio of 10.4. The shares of Johnson & Johnson are trading at $154.8. .

Organization	Johnson & Johnson
Employees	131900
CEO	Mr. Joaquin Duato
Industry	Health Technology

Important FAQs about investing in Johnson & Johnson from India :

What is Johnson & Johnson share price today?

Johnson & Johnson (JNJ) share price today is $154.80.

Can Indians buy Johnson & Johnson shares?

Yes, Indians can invest in the Johnson & Johnson (JNJ) from India.

With INDmoney, you can buy Johnson & Johnson at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Johnson & Johnson at zero transaction cost.

How can I buy Johnson & Johnson shares from India?

It is very easy to buy Johnson & Johnson from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Johnson & Johnson be purchased?

Yes, you can buy fractional shares of Johnson & Johnson with INDmoney app.

What are the documents required to start investing in Johnson & Johnson stocks?

To start investing in Johnson & Johnson, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.